Dr. Neeta Malviya, MD

Dr. Malviya practices at Sutter Imaging Elk Grove in Elk Grove, California.

Dr. Malviya's NPI, 1487189593, was assigned on April 26, 2017. Dr. Malviya graduated from UT Southwestern Medical Center in 2017. Dr. Malviya's California license number on file is A174109.

Dr. Malviya's primary practice is Sutter Imaging Elk Grove, at 8170 Laguna Blvd. Suite 112, Elk Grove, CA 95758. The practice phone is (916) 691-5922.

Dr. Malviya's primary practice is Sutter Imaging Elk Grove in Elk Grove, California. Dr. Malviya is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Malviya to 1 more group practice or clinic, named with a free account. Dr. Malviya's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malviya practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Malviya's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Malviya is board certified in dermatology by the American Board of Dermatology. Dr. Malviya has a license on file in California.

Dmand AI lists acne, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes, psoriasis and scalp rash among the conditions Dr. Malviya treats.

CMS data shows 2,815 Medicare services from Dr. Malviya across 15 procedure codes in 2024, for 655 Medicare patients. Medicare paid $153,391 for them. Every service was in an office.

CMS counts 655 Medicare patients who saw Dr. Malviya in 2024. The largest group is 65 to 74, with 298 patients. 68% of them have high cholesterol, and 66% have high blood pressure. 9% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Malviya's median patient age at 64, with 59% women.

In 2024, Dr. Malviya wrote 1,602 Medicare Part D claims for 494 patients. 89% of them were for generic drugs. CMS names the drug for 1,468 of them, across 22 drugs with 11 or more claims each, at $406,479 in total drug cost. In 2023, CMS named 1,010 claims across 20 drugs.

Dr. Malviya accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Malviya as offering telehealth. CMS counts 927 procedures of removal of skin lesions by Dr. Malviya, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Malviya, published from 2016 to 2023. 2017 was the busiest year, with 4. The most frequent topics are Immunohistochemistry, Pyoderma Gangrenosum and Scleroderma, Localized. Dr. Malviya has published most often in Dermatol Surg. Dr. Malviya's most frequent co-authors are Nika K. Cyrus, MD, Travis Wade Vandergriff, MD and Afsaneh Alavi, MD.

CMS Open Payments shows 59 general payments to Dr. Malviya from 19 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 95% of the total. Eli Lilly and Company paid the most, $713.

Dr. Malviya graduated from UT Southwestern Medical Center in 2017.

Dr. Malviya is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.